A detailed history of Steward Financial Group LLC transactions in Biogen Inc. stock. As of the latest transaction made, Steward Financial Group LLC holds 66 shares of BIIB stock, worth $10,392. This represents 0.01% of its overall portfolio holdings.

Number of Shares
66
Previous 66 -0.0%
Holding current value
$10,392
Previous $18,000 11.11%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 04, 2023

SELL
$275.25 - $318.06 $825 - $954
-3 Reduced 4.35%
66 $18,000
Q1 2023

May 05, 2023

BUY
$256.56 - $292.34 $9,749 - $11,108
38 Added 122.58%
69 $19,000
Q4 2022

Feb 13, 2023

BUY
$252.44 - $306.72 $7,825 - $9,508
31 New
31 $8,000
Q2 2022

Jul 22, 2022

BUY
$187.54 - $223.02 $6,938 - $8,251
37 New
37 $7,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.